Effects of combined dietary chromium(III) propionate complex and thiamine supplementation on insulin sensitivity, blood biochemical indices, and mineral levels in high-fructose-fed rats

Biological Trace Element Research

Volumn 150, Issue 1-3, 2012, Pages 350-359

  Król, Ewelina ^a   Krejpcio, Zbigniew ^a   Michalak, Sławomir ^b   Wójciak, Rafał W ^a,b   Bogdański, Paweł ^b  

^a POZNA UNIVERSITY OF LIFE SCIENCES   (Poland)

^b POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Chromium(III) propionate complex; Insulin resistance; Rats; Supplementation; Thiamine

Indexed keywords

CHROMIUM; COPPER; FRUCTOSE; INTERLEUKIN 2; THIAMINE; TRANSKETOLASE; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; ZINC;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD ANALYSIS; BODY MASS; CARBOHYDRATE METABOLISM; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY INTAKE; FOOD INTAKE; GLUCOSE INTOLERANCE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LABORATORY TEST; LIPID METABOLISM; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUTRITIONAL SUPPORT; OXIDATIVE STRESS; RAT; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; CHROMIUM; COPPER; DIETARY SUPPLEMENTS; FRUCTOSE; GLUCOSE INTOLERANCE; HYPERGLYCEMIA; HYPERLIPIDEMIAS; HYPOGLYCEMIC AGENTS; HYPOLIPIDEMIC AGENTS; INSULIN RESISTANCE; KIDNEY; LIVER; MALE; PREDIABETIC STATE; PROPIONATES; RATS; RATS, WISTAR; THIAMINE; TISSUE DISTRIBUTION; ZINC;

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

EID: 84870711817     PISSN: 01634984     EISSN: 15590720     Source Type: Journal    
DOI: 10.1007/s12011-012-9515-5     Document Type: Article

References (66)

1. Smyth S, Heron A (2006) Diabetes and obesity: the twin epidemics. Nat Med 12(1):75-80
2. Koh-Banerjee P, Wang Y, Hu FB, Spiegelman D, Willett WC, Rimm EB (2004) Changes in body weight and body fat distribution as risk factors for clinical diabetes in US men. Am J Epidemiol 159:1150-1159
3. Muoio DM, Newgard CB (2008) Mechanisms of disease: molecular and metabolic mechanisms of insulin resistance and beta-cell failure in type 2 diabetes. Nat Rev Mol Cell Biol 9:193-205
4. Gillies CL, Abrams KR, Lambert PC, Cooper NJ, Sutton AJ, Hsu RT, Khunti K (2007) Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis. BMJ 334:299
5. Stallings D, Vincent JB (2006) Chromium. A case study in how not to perform nutritional research. Curr Topics Nutraceut Res 4:89-112
6. Hua Y, Clark S, Ren J, Sreejayan N (2012) Molecular mechanisms of chromium in alleviating insulin resistance. J Nutr Biochem 23(4):313-319
7. Pei D, Hsieh CH, Hung YJ, Li JC, Lee CH, Kuo SW (2006) The influence of chromium chloride-containing milk to glycemic control of patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled trial. Metabolism 55:923-927
8. Racek J, Trefil L, Rajdl D, Mudrova V, Hunter D, Senft V (2006) Influence of chromium-enriched yeast on blood glucose and insulin variables, blood lipids, and markers of oxidative stress in subjects with type 2 diabetes mellitus. Biol Trace Elem Res 109:215-230
9. Sharma S, Prasad Agrawa R, Choudhary M, Jain S, Goya S, Agarwal V (2011) Beneficial effect of chromium supplementation on glucose, HbA1C and lipid variables in individuals with newly onset type-2 diabetes. J Trace Elem Med Biol 25:149-153
10. Gunton JE, Cheung NW, Hitchman R, Hams G, O'Sullivan C, Foster-Powell K, McElduff A (2005) Chromium supplementation does not improve glucose tolerance, insulin sensitivity, or lipid profile: a randomized, placebo-controlled, double-blind trial of supplementation in subjects with impaired glucose tolerance. Diabetes Care 28:712-713
11. Kleefstra N, Houweling S, Jansman FGA, Groenier KH, Gans ROB, Mayboom-de Jong B, Bakker SJ, Bilo HJ (2006) Chromium treatment has no effect in patients with poorly controlled, insulin-treated type 2 diabetes in an obese Western population: a randomized, double-blind, placebo-controlled trial. Diabetes Care 29:521-525
12. Król E, Krejpcio Z, Byks H, Bogdański P, Pupek-Musialik D (2011) Effects of chromium brewer's yeast supplementation on body mass, blood carbohydrates, and lipids and minerals in type 2 diabetic patients. Biol Trace Elem Res 143(2):726-737
13. DiBona KR, Love S, Rhodes NR, McAdory D, Sinha SH, Kern N, Kent J, Strickland J, Wilson A, Beaird J, Ramage J, Rasco JF, Vincent JB (2011) Chromium is not an essential trace element for mammals: effects of a low-chromium diet. J Biol Inorg Chem 16:381-390
14. Król E, Krejpcio Z (2011) Evaluation of anti-diabetic potential of chromium(III) propionate complex in high-fat diet fed and STZ injected rats. Food Chem Toxicol 49(12):3217-3223
15. Beltramo E, Berrone E, Tarallo S, Porta M (2008) Effects of thiamine and benfotiamine on intracellular glucose metabolism and relevance in the prevention of diabetic complications. Acta Diabetol 45(3):131-141
16. Babaei-Jadidi R, Karachalias N, Kupich C, Ahmed N, Thornalley PJ (2004) High-dose thiamine therapy counters dyslipidaemia in streptozotocin-induced diabetic rats. Diabetologia 47(12):2235-2246
17. La Selva M, Beltramo E, Pagnozzi F, Bena E, Molinatti PA, Molinatti GM, Porta M (1996) Thiamine corrects delayed replication and decreases production of lactate and advanced glycation end-products in bovine retinal and human umbilical vein endothelial cells cultured under high glucose conditions. Diabetologia 39(11):1263-1268
18. Page GL, Laight D, Cummings MH (2011) Thiamine deficiency in diabetes mellitus and the impact of thiamine replacement on glucose metabolism and vascular disease. Int J Clin Pract 65(6):684-690
19. Thameem F, Wolford JK, Bogardus C, Prochazka M (2001) Analysis of SLC19A2, on 1q23.3 encoding a thiamine transporter as a candidate gene for type 2 diabetes mellitus in Pima Indians. Mol Genet Metab 72(4):360-363
20. Oishi K, Hofmann S, Diaz GA, Brown T, Manwani D, Ng L, Young R, Vlassara H, Ioannou YA, Forrest D, Gelb BD (2002) Targeted disruption of SLCA19A2, the gene encoding the high-affinity thiamin transporter Thtr-1, causes diabetes mellitus, sensorineural deafness and megaloblastosis in mice. Hum Mol Genet 11(23):2951-2960
21. Thornalley PJ, Babaei-Jadidi R, Al Ali H, Rabbani N, Antonysunil A, Larkin J, Ahmed A, Rayman G, Bodmer CW (2007) High prevalence of low plasma thiamine concentration in diabetes linked to a marker of vascular disease. Diabetologia 50(10):2164-2170
22. Kohda Y, Umeki M, Kono T, Terasaki F, Matsumura H, Tanaka T (2010) Thiamine ameliorates diabetes-induced inhibition of pyruvate dehydrogenase (PDH) in rat heart mitochondria: investigating the discrepancy between PDH activity and PDH E1alpha phosphorylation in cardiac fibroblasts exposed to high glucose. J Pharmacol Sci 113(4):343-352
23. Pácal L, Tomandl J, Svojanovsky J, Krusová D, Stepánková S, Rehorová J, Olsovsky J, Belobrá dková J, Tanhäuserová V, Tomandlová M, Muzík J, Kanková K (2011) Role of thiamine status and genetic variability in transketolase and other pentose phosphate cycle enzymes in the progression of diabetic nephropathy. Nephrol Dial Transplant 26(4):1229-1236
24. Rabbani N, Thornalley PJ (2011) Emerging role of thiamine therapy for prevention and treatment of early-stage diabetic nephropathy. Diabetes Obes Metab 13(7):577-583
25. Katare RG, Caporali A, Oikawa A, Meloni M, Emanueli C, Madeddu P (2010) Vitamin B1 analog benfotiamine prevents diabetes-induced diastolic dysfunction and heart failure through Akt/Pim-1-mediated survival pathway. Circ Heart Fail 3(2):294-305
26. Król E, Krejpcio Z (2010) Chromium(III) propionate complex supplementation improves carbohydrate metabolism in insulin-resistance rat model. Food Chem Toxicol 48:2791-2796
27. Reeves PG, Nielsen FH, Fahey GC Jr (1993) AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 123:1939-1951
28. Earnshaw A, Figgis BN, Lewis J (1966) Chemistry of polynuclear compounds Part VI. Magnetic properties of trimeric chromium and iron carboxylates. J Chem Soc A 1966:1656-1663
29. Albanese AA, Brin M (1967) Functional evaluation of nutritional status: thiamine. In: Albanese AA (ed) Newer methods of nutrition biochemistry. Academic, New York, pp 407-445
30. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419
31. Cerulli J, Grabe DW, Gauthier I, Malone M, McGoldrick MD (1998) Chromium picolinate toxicity. Ann Pharmacother 32(4):428-431
32. Stumvoll M, Gerich J (2001) Clinical features of insulin resistance and beta cell dysfunction and the relationship to type 2 diabetes. Clin Lab Med 21(1):31-51
33. Garaulet M, Madrid JA (2010) Chronobiological aspects of nutrition, metabolic syndrome and obesity. Adv Drug Deliv Rev 62:967-978
34. Harton A, Terrell K, Huffman JC, MacDonald C, Beatty A, Li S, O'Connor CJ, Vincent JB (1997) Synthesis and characterization of novel oxo-bridged dinuclear and hydroxo-bridged trinuclear chromium(III) assemblies. Inorg Chem 36:4875-4882
35. Clodfelder BJ, Chang C, Vincent JB (2004) Absorption of the biomimetic chromium cation triaqua-l-oxo-hexapropionatotrichromium(III) in rats. Biol Trace Elem Res 98:159-169
36. 3] + decreases plasma insulin, cholesterol, and triglicerides in healthy and type II diabetic rats but not type I diabetic rats. J Biol Inorg Chem 7:852-862
37. Clodfelder BJ, Emamaullee J, Hepburn DD, Chakov NE, Nettles HS, Vincent JB (2001) The trail of chromium(III) in vivo from the blood to the urine: the roles of transferrin and chromodulin. J Biol Inorg Chem 6:608-617
38. 3] + increases insulin sensitivity and improves blood plasma variables in healthy and type 2 diabetic rats. J Biol Inorg Chem 10:119-130
39. Clodfelder BJ, Vincent JB (2005) The time-dependent transport of chromium in adult rats from the bloodstream to the urine. J Biol Inorg Chem 10:383-393
40. Rathanaswami P, Pourany A, Sundaresan R (1991) Effects of thiamine deficiency on the secretion of insulin and the metabolism of glucose in isolated rat pancreatic islets. Biochem Int 25(3):577-583
41. Rathanaswami P, Sundaresan R (1991) Effects of thiamine deficiency on the biosynthesis of insulin in rats. Biochem Int 24(6):1057-1062
42. WHO/FAO (2004) Vitamin and mineral requirements in human nutrition, 2nd edn. World Health Organization, Geneva, 165-168
43. Berrone E, Beltramo E, Solimine C, Ape AU, Porta M (2006) Regulation of intracellular glucose and polyol pathway by thiamine and benfotiamine in vascular cells cultured in high glucose. J Biol Chem 281:9307-9313
44. Karachalias N, Babaei-Jadidi R, Rabbani N, Thornalley PJ (2010) Increased protein damage in renal glomeruli, retina, nerve, plasma and urine and its prevention by thiamine and benfotiamine therapy in a rat model of diabetes. Diabetologia 53(7):1506-1516
45. González-Ortiz M, Martínez-Abundis E, Robles-Cervantes JA, Ramírez-Ramírez V, Ramos-Zavala MG (2011) Effect of thiamine administration on metabolic profile, cytokines and inflammatory markers in drug-naïve patients with type 2 diabetes. Eur J Nutr 50(2):145-149
46. Lukienko PI, Mel'nichenko NG, Zverinskii IV, Zabrodskaya SV (2000) Antioxidant properties of thiamine. Bull Exp Biol Med 130(9):874-876
47. Schmid U, Stopper H, Heidland A, Schupp N (2008) Benfotiamine exhibits direct antioxidative capacity and prevents induction of DNA damage in vitro. Diabetes Metab Res Rev 24:371-377
48. Schupp N, Dette EM, Schmid U, Bahner U, Winkler M, Heidland A, Stopper H (2008) Benfotiamine reduces genomic damage in peripheral lymphocytes of hemodialysis patients. Naunyn Schmiedebergs Arch Pharmacol 378:283-291
49. Balakumar P, Chakkarwar VA, Singh M (2009) Ameliorative effect of combination of benfotiamine and fenofibrate in diabetes-induced vascular endothelial dysfunction and nephropathy in the rat. Mol Cell Biochem 320:149-162
50. Verma S, Reddy K, Balakumar P (2010) The defensive effect of benfotiamine in sodium arsenite-induced experimental vascular endothelial dysfunction. Biol Trace Elem Res 137:96-109
51. Feinstein R, Kanety H, Papa MZ, Lunenfeld B, Karasik A (1993) Tumor necrosis factor-α suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates. J Biol Chem 268:26055-26058
52. Hotamisligil GS, Shargill NS, Spiegelman BM (1993) Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance. Science 259:87-91
53. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM (1994) Positional cloning of the mouse obese gene and its human homologue. Nature 372:425-432
54. Fried SK, Bunkin DA, Greenberg AS (1998) Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab 83:847-850
55. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS, Lazar MA (2001) The hormone resistin links obesity to diabetes. Nature 409:307-312
56. Fukuhara A, Matsuda M, Nishizawa M, Segawa K, Tanaka M, Kishimoto K, Matsuki Y, Murakami M, Ichisaka T, Murakami H, Watanabe E, Takagi T, Akiyoshi M, Ohtsubo T, Kihara S, Yamashita S, Makishima M, Funahashi T, Yamanaka S, Hiramatsu R, Matsuzawa Y, Shimomura I (2005) Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 307:426-430
57. Penttinen J (1995) High plasma interleukin-2: a potential cause of insulin resistance. Med Hypothesis 45(6):614-616
58. Jain SK, Rains JL, Croad JL (2007) Effect of chromium niacinate and chromium picolinate supplementation on lipid peroxidation, TNF-alpha, IL-6, CRP, glycated hemoglobin, triglycerides, and cholesterol levels in blood of streptozotocin-treated diabetic rats. Free Radic Biol Med 43(8):1124-1131
59. Jain SK, Croad JL, Velusamy T, Rains JL, Bull R (2010) Chromium dinicocysteinate supplementation can lower blood glucose, CRP, MCP-1, ICAM-1, creatinine, apparently mediated by elevated blood vitamin C and adiponectin and inhibition of NFkappaB, Akt, and Glut-2 in livers of zucker diabetic fatty rats. Mol Nutr Food Res 54(9):1371-1380
60. Dogukan A, Sahin N, Tuzcu M, Juturu V, Orhan C, Onderci M, Komorowski J, Sahin K (2009) The effects of chromium histidinate on mineral status of serum and tissue in fat-fed and streptozotocin-treated type II diabetic rats. Biol Trace Elem Res 131:124-132
61. Sahin K, Gülar T, Sahin N, Ertas ON, Erkal N (1999) The effect of chromium added into basal diet on serum total protein, urea, triglyceride, cholesterol and serum and tissue chromium, zinc, copper levels in rabbits. Tr J Vet Anim Sci 23:109-113
62. Agte VV, Nagmote RV, Tarwadi KV (2004) Comparative in vitro uptake of zinc by erythrocytes of normal vs Type 2 diabetic individuals and the associated factors. Diabetes Nutr Metab 17(6):343-349
63. Tupe RS, Agte VV (2010) Effect of water soluble vitamins on Zn transport of Caco-2 cells and their implications under oxidative stress conditions. Eur J Nutr 49(1):53-61
64. Tandon SK, Prasad S (2000) Effect of thiamine on the cadmium-chelating capacity of thiol compounds. Hum Exp Toxicol 19(9):523-528
65. 2 EDTA and thiamine. J Vet Diagn Invest 7(4):531-537
66. Kim JS, Hamilton DL, Blakley BR, Rousseaux CG (1992) The effects of thiamin on lead metabolism: organ distribution of lead 203. Can J Vet Res 56(3):256-259